You likely heard recently that former hedge fund manager-turned-entreperneur Martin Shkreli’s company, Turing Pharmaceuticals, bought the patent to a drug treating toxoplasmosis, a potentially deadly parasite disease, increasing the per pill cost from $13.50 to $750. (Before being sold several…